[HTML][HTML] Recent advances in novel lateral flow technologies for detection of COVID-19

WWW Hsiao, TN Le, DM Pham, HH Ko, HC Chang… - Biosensors, 2021 - mdpi.com
The development of reliable and robust diagnostic tests is one of the most efficient methods
to limit the spread of coronavirus disease 2019 (COVID-19), which is caused by the severe …

[HTML][HTML] Challenges in the detection of SARS-CoV-2: evolution of the lateral flow immunoassay as a valuable tool for viral diagnosis

NS Castrejón-Jiménez, BE García-Pérez… - Biosensors, 2022 - mdpi.com
SARS-CoV-2 is an emerging infectious disease of zoonotic origin that caused the
coronavirus disease in late 2019 and triggered a pandemic that has severely affected …

[HTML][HTML] Development and efficacy of lateral flow point-of-care testing devices for rapid and mass COVID-19 diagnosis by the detections of SARS-CoV-2 antigen and …

WY Hsieh, CH Lin, TC Lin, CH Lin, HF Chang, CH Tsai… - Diagnostics, 2021 - mdpi.com
The COVID-19 pandemic is an ongoing global pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2020–2021. COVID-19 is becoming …

[HTML][HTML] Recent progress on rapid lateral flow assay-based early diagnosis of COVID-19

Y Zhang, Y Chai, Z Hu, Z Xu, M Li, X Chen… - … in Bioengineering and …, 2022 - frontiersin.org
The outbreak of the coronavirus disease 2019 (COVID-19) has resulted in enormous losses
worldwide. Through effective control measures and vaccination, prevention and curbing …

Point-of-care COVID-19 diagnostics powered by lateral flow assay

Y Zhou, Y Wu, L Ding, X Huang, Y Xiong - TrAC Trends in Analytical …, 2021 - Elsevier
Since its first discovery in December 2019, the global coronavirus disease 2019 (COVID-19)
pandemic caused by the novel coronavirus (SARS-CoV-2) has been posing a serious threat …

Sandwich mode lateral flow assay for point-of-care detecting SARS-CoV-2

F Pei, S Feng, W Hu, B Liu, X Mu, Q Hao, Y Cao, W Lei… - Talanta, 2023 - Elsevier
The global corona virus disease 2019 (COVID-19) has been announced a pandemic
outbreak, and has threatened human life and health seriously. Severe acute respiratory …

SERS based lateral flow immunoassay for point-of-care detection of SARS-CoV-2 in clinical samples

S Yadav, MA Sadique, P Ranjan, N Kumar… - ACS Applied Bio …, 2021 - ACS Publications
The current scenario, an ongoing pandemic of COVID-19, places a dreadful burden on the
healthcare system worldwide. Subsequently, there is a need for a rapid, user-friendly, and …

[HTML][HTML] Lateral flow test engineering and lessons learned from COVID-19

J Budd, BS Miller, NE Weckman, D Cherkaoui… - Nature Reviews …, 2023 - nature.com
The acceptability and feasibility of large-scale testing with lateral flow tests (LFTs) for clinical
and public health purposes has been demonstrated during the COVID-19 pandemic. LFTs …

Lateral flow assays (LFA) as an alternative medical diagnosis method for detection of virus species: The intertwine of nanotechnology with sensing strategies

P Sadeghi, H Sohrabi, M Hejazi… - TrAC Trends in …, 2021 - Elsevier
Viruses are responsible for multiple infections in humans that impose huge health burdens
on individuals and populations worldwide. Therefore, numerous diagnostic methods and …

Rapid field determination of SARS-CoV-2 by a colorimetric and fluorescent dual-functional lateral flow immunoassay biosensor

H Han, C Wang, X Yang, S Zheng, X Cheng… - Sensors and Actuators B …, 2022 - Elsevier
The rapid and accurate diagnosis of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) at the early stage of virus infection can effectively prevent the spread of the …